T
Healthcare and Life Sciences
Tausif Qudsi
Answer 1
Views 467
0

PD-1/PDL-1 Inhibitor Market

What is the average total number or percentage of locally advanced or metastatic urothelial carcinoma patients?

Oncology

immunoncology

Therapeutics

cancer